These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30051594)

  • 1. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
    Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
    Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
    Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
    J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines.
    Miekus K; Jarocha D; Trzyna E; Majka M
    Folia Histochem Cytobiol; 2010 Jan; 48(1):104-11. PubMed ID: 20529825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
    Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
    Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
    Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
    Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR7 impact on CXCL12 biology and disease.
    Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
    Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
    Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
    J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
    Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas.
    Yu H; Zhang L; Liu P
    Tumour Biol; 2015 Mar; 36(3):1679-83. PubMed ID: 25359618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDF-1/CXCR7 axis enhances ovarian cancer cell invasion by MMP-9 expression through p38 MAPK pathway.
    Yu Y; Li H; Xue B; Jiang X; Huang K; Ge J; Zhang H; Chen B
    DNA Cell Biol; 2014 Aug; 33(8):543-9. PubMed ID: 24819308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
    Hung YC; Chang WC; Chen LM; Chang YY; Wu LY; Chung WM; Lin TY; Chen LC; Ma WL
    J Cell Physiol; 2014 Jun; 229(6):752-61. PubMed ID: 24142535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.
    Lau TS; Chung TK; Cheung TH; Chan LK; Cheung LW; Yim SF; Siu NS; Lo KW; Yu MM; Kulbe H; Balkwill FR; Kwong J
    J Pathol; 2014 Jan; 232(1):43-56. PubMed ID: 24014111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
    Koch C; Fischer NC; Puchert M; Engele J
    BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
    Monnier J; Boissan M; L'Helgoualc'h A; Lacombe ML; Turlin B; Zucman-Rossi J; Théret N; Piquet-Pellorce C; Samson M
    Eur J Cancer; 2012 Jan; 48(1):138-48. PubMed ID: 21778049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
    Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
    Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR7 functions as a scavenger for CXCL12 and CXCL11.
    Naumann U; Cameroni E; Pruenster M; Mahabaleshwar H; Raz E; Zerwes HG; Rot A; Thelen M
    PLoS One; 2010 Feb; 5(2):e9175. PubMed ID: 20161793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen represses CXCR7 gene expression by inhibiting the recruitment of NFκB transcription factor at the CXCR7 promoter in breast cancer cells.
    Kerdivel G; Boudot A; Pakdel F
    Biochem Biophys Res Commun; 2013 Feb; 431(4):729-33. PubMed ID: 23352615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.